WO2002020499A1 - Process for the preparation of 2-[3,4-dihydro-1,4-benzothiazin-4-yl]ethylmethane sulphonate - Google Patents

Process for the preparation of 2-[3,4-dihydro-1,4-benzothiazin-4-yl]ethylmethane sulphonate Download PDF

Info

Publication number
WO2002020499A1
WO2002020499A1 PCT/IB2001/001614 IB0101614W WO0220499A1 WO 2002020499 A1 WO2002020499 A1 WO 2002020499A1 IB 0101614 W IB0101614 W IB 0101614W WO 0220499 A1 WO0220499 A1 WO 0220499A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
dihydro
benzothiazin
ethanol
compound
Prior art date
Application number
PCT/IB2001/001614
Other languages
French (fr)
Inventor
Chandrasekhar Batchu
Om Reddy Gaddam
Satyanarayana Vara Prasad Reddy Tetali
Original Assignee
Dr. Reddy's Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Research Foundation filed Critical Dr. Reddy's Research Foundation
Priority to AU2001284335A priority Critical patent/AU2001284335A1/en
Publication of WO2002020499A1 publication Critical patent/WO2002020499A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Definitions

  • the present invention relates to a process for the preparation of 2-[3,4- dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1).
  • the compound of formula (1) is an intermediate for the preparation of many pharmaceutically active compounds.
  • Scheme-1 Z hi-Z Huang [Org. Prep. Proced. Int., 28, 121, (1996)] described the process for preparation of 2-(3,4-dihydro-3-oxo-l,4-benzothiazin-4-yl)acetic acid (6) by rapid N-alkylation of 3- ⁇ xo-3,4-dihydro-l,4-benzothiazine of the formula (2) with bromoacetic acid (5) using sodium ethoxide catalyst and silica gel as support under Microwave irradiation in about 8-10 min.
  • the reaction is shown in scheme-2 below :
  • the main objective of the present invention is to provide a process for the preparation of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) from hitherto known N-alkylated benzothiazine of the formula (7) or from 3,4-dihydro-l,4-benzothiazine of formula (10).
  • the present invention provides a process for the preparation of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) which comprises : i). reducing the N-alkylated benzothiazine of the formula (7) where R is hydrogen or ethyl in the presence of a solvent at a temperature in the range of 5 .°C - reflux temperature, to get 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l- ethanol of formula (8), ii).
  • N-alkylated compound of formula (7) where R is hydrogen or ethyl to a compound of formula (8) may be carried out using metal hydride reducing agents such as LAH or NaBH 4 /Iodine or NaBH /CH 3 SO 3 H or bis(2-methoxyethoxy)aluminum hydride (REDAL), in the presence of solvents such as diethylether, diisopropyl ether, tetrahydrofuran and the like.
  • the temperature of the reaction may range from 5 °C - reflux temperature of the solvent used, preferably at a temperature in the range of 60 °C to reflux temperature.
  • the yield of the resultant 2-[3,4-dihydro- l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) is in the order of 60-75 % and purity of 90-95 %.
  • This compound can be used directly for the next step without purification.
  • the reaction of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l- ethanol of the formula (8) with methane sulphonyl chloride may be carried out in the presence of an organic solvent such as DCE, DCM, toluene and the like, and an organic base such as triethylamine, tributylamine and the like.
  • the final compound namely 2-[3,4-dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) is obtained in quantitative yield and of purity 99 %•
  • the N-alkylation of compound of formula (9) with 2-haloethanol of compound of the formula (10) wherein X represents halogen atom such as chlorine, bromine, fluorine or iodine in the step (i) may be carried out in the presence of base such as triethylamine, tributylamine, diisopropylamine, tetramethylguanidine and the like.
  • the temperature for the reaction may range from 110 °C to 220 °C, preferably at 150-200 °C.
  • the yield of the resultant 2- [3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) is in the order of 75-85 % and purity of ⁇ 90 %.
  • This compound can be used directly for the next step without purification as the impurities can be eliminated in the subsequent steps.
  • the reaction of 2-[3,4-dihydro-l 5 4-benzothiazin-4-yl]-l- ethanol of formula (8) with methane sulphonyl chloride may be carried out in the presence of organic solvent such as DCM, DCE, toluene and the like and an organic base selected from ethylamine, tributylamine and the like.
  • organic solvent such as DCM, DCE, toluene and the like
  • organic base selected from ethylamine, tributylamine and the like.
  • the final compound namely of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) is obtained in 70-80 % yield and of purity 99 %.
  • Step (i) 2-r3,4-Dihvdro-l,4-benzothiazin-4-yl1-l-ethanol of the formula (8) : Lithium aluminum hydride (80 g) was added slowly under dry nitrogen atmosphere into 5 L 4 necked round bottom flask in about 30 min. The reaction mixture was cooled to 10-15 °C and THF (500 ml) was added dropwise in about 30-60 min. The reaction mixture was stirred at 10-15 °C for
  • Step (ii) 2-r3,4-Dihydro-l,4-benzotl iazin-4-yllethylmethane sulphonate of the formula (1) :
  • Step (i) 2-[3,4-Dihydro-l,4-benzothiazin-4-yn-l-ethanol of the formula (8) :
  • Sodium borohydride (2.70 g) was taken in 250 ml 3 necked round bottom flask and THF (20 ml) was added with stirring under nitrogen atmosphere.
  • Iodine (9.25 g) dissolved in THF (40 ml) was added to the above mixture of sodium borohydride at -10 to 0 °C in about 30-45 min. through addition funnel.
  • the DCM layer was washed with water (30 ml), dried over Na 2 SO 4 , distill off the DCM under reduced pressure in a rotavapour to obtain 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8) as an oil, (weighs about 4 g, yield 67 %, purity 92-95 % by HPLC).
  • Step (ii) 2-r3,4-Dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) :
  • Step (i) 2-r3 -Dihvdro-l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) :
  • Sodium borohydride (2.70 g) was taken in 250 ml 3 necked round bottom flask and THF (20 ml) was added under stirring under nitrogen atmosphere.
  • Methane sulfonic acid (3.5 g) dissolved in THF (40 ml) was added to the above mixture of sodium borohydride at -10 to 0 °C in about 30-45 min. through addition funnel.
  • Step (ii) 2-r3,4-Dihvdro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) :
  • Example 4 Step (i) 2-r3,4-Dihydro-l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) : To 3,4-dihydro-l,4-benzothiazine (200 g) taken in 2 L 4 necked round bottom flask, 2-chloroethanol (131 g, ⁇ 109 ml) and tributylamine (302 g, -393 ml) was added under stirring at 25 to 35 °C in one lot. The reaction mixture was heated to 170 to 180 °C under vigorous stirring and maintained the reaction mixture at that temperature for 4-6 h. Monitored the reaction by TLC.
  • reaction mixture was cooled to 25 to 35 °C and toluene (1 L) was added, washed the organic layer with water (3 x 1 L) and decolorized with activated charcoal.
  • the decolorized organic layer was concentrated on rotavapor at 80- 90 °C under reduced pressure and the residual oil was stirred with petroleum ether (1 L) for 30 min. and separated the per. ether layer. Repeated the petroleum stirring for two times and separated the pet.
  • Step (ii) 2-r3,4-Dihvdro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) :
  • Step (i) 2-r3,4-Dihydro-l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) : To 3,4-dihydro-l,4-benzothiazine (200 g) taken in 2 L 4 necked round bottom flask, bromoethanol (206 g, -117 ml) and tributylamine (302 g, -393 ml) was added under stirring at 25 to 35 °C in one lot. The reaction mixture was heated to 170-180 °C under vigorous stirring and maintained the reaction mixture at that temperature for 4-6 h. Monitored the reaction by TLC.
  • reaction mixture was cooled to 25 to 35 °C and toluene (1 L) was added, washed the organic layer with water (3 x 1 L) and decolorized with activated charcoal.
  • the decolorized organic layer was concentrated on rotavapor at 80 to 90 °C under reduced pressure and the residual oil was stirred with petroleum ether (1 L) for 30 min. and separated the pet. ether layer. Repeated the petroleum stirring for two times and separated the pet.
  • Step (ii) 2-r3,4-Dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) : To a solution of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8) (220 g) obtained in step (i) above in dichloromethane (1100 ml), triethylamine (199 g, -275 ml) was added under nitrogen atmosphere dropwise at 25 to 35 °C. Methanesulfonyl chloride (194 g, -132 ml) was added to the above reaction mixture at 0 to 5 °C under stirring.
  • Example 6 Step (i) 2-r3,4-Dihydro-l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) : To 3,4-dil ydro-l,4-benzothiazine (200 g) taken in 2 L 4 necked round bottom flask, iodoethanol (284 g, -129 ml) and tributylamine (302 g, -393 ml) was added under stirring at 25 to 35 °C in one lot. The reaction mixture was heated to 170 to 180 °C under vigorous stirring and maintained the reaction mixture at that temperature for 4-6 h. Monitored the reaction by TLC.
  • reaction mixture was cooled to 25 to 35 °C and toluene (1 L) was added, washed the organic layer with water (3 x 1 L) and decolorized with activated charcoal.
  • the decolorized organic layer was concentrated on rotavapor at 80 to 90 °C under reduced pressure and the residual oil was stirred with petroleum ether (1 L) for 30 min. and separated the pet. ether layer. Repeated the petroleum stirring for two times and separated the pet.
  • Step (ii) 2-r3,4-Dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) :

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A process for the preparation of 2-[3,4-dihydro-1,4-benzothiazin-4-yl]ethylmethane sulphonate of formula (1) which comprises reducing the N-alkylated benzothiazine of the formula (7) where R is hydrogen or ethyl at a temperature in the range of 10 - 70 °C or N-alkylating the 3,4-dihydro-1,4-benzothiazine with 2-haloethanol at a temperature in the range of 110-220 °C, in the presence of a base to get 2-[3,4-dihydro-1,4-benzothiazin-4-yl]ethanol, mesylating the 2-[3,4-dihydro-1,4-benzothiazin-4-yl]-1-ethanol to a compound of formula (1) by treating with methane sulphonyl chloride in the presence of an organic base and an organic solvent and isolating the compound of formula (1) by conventional methods.

Description

PROCESS FOR THE PREPARATION OF 2-[3,4-DIHYDRO-l,4- BENZOTHIAZIN-4-YL]ETHYLMETHANE SU PHONATE
Field of the invention
The present invention relates to a process for the preparation of 2-[3,4- dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1).
Figure imgf000002_0001
The compound of formula (1) is an intermediate for the preparation of many pharmaceutically active compounds.
In view of the importance of the compound of formula (1), we observed that the process for the preparation of compound of formula (1) is not reported in the literature.
Several synthetic routes have been developed for the analogues of formula (1).
A. Marfat [synthesis., 5, 515 (1987)] described the process for preparation of ethyl 2-(3,4-dihydro-3-oxo-l,4-benzothiazin-4-yl)acetate (4) by alkylation of 3,4-dihydro-3-oxo-l,4-benzothizine of the formula (2) with ethyl bromoacetate (3) in DMF containing t-BuOK in about 30 min. The reaction is shown in scheme- 1 below :
Figure imgf000002_0002
Scheme-1 Z hi-Z Huang [Org. Prep. Proced. Int., 28, 121, (1996)] described the process for preparation of 2-(3,4-dihydro-3-oxo-l,4-benzothiazin-4-yl)acetic acid (6) by rapid N-alkylation of 3-όxo-3,4-dihydro-l,4-benzothiazine of the formula (2) with bromoacetic acid (5) using sodium ethoxide catalyst and silica gel as support under Microwave irradiation in about 8-10 min. The reaction is shown in scheme-2 below :
Figure imgf000003_0001
scheme-2
Objective of the invention
The main objective of the present invention is to provide a process for the preparation of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) from hitherto known N-alkylated benzothiazine of the formula (7) or from 3,4-dihydro-l,4-benzothiazine of formula (10).
Therefore, we directed our research work to develop a process for the preparation of the said compound of formula (1) with the objective of developing efficient, economical and commercially viable process employing cheap and easily available raw materials, involving simple reaction steps.
Detailed Description of the Invention
Accordingly, the present invention provides a process for the preparation of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1)
Figure imgf000004_0001
which comprises : i). reducing the N-alkylated benzothiazine of the formula (7) where R is hydrogen or ethyl in the presence of a solvent at a temperature in the range of 5 .°C - reflux temperature, to get 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l- ethanol of formula (8), ii). mesylating the 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) obtained in step (i) to the compound of formula (1) by treating with methane sulphonyl chloride in the presence of an organic base and an organic solvent and
(iii). isolating the compound of formula (1) by conventional methods.
The reaction is shown in scheme-3 below :
Figure imgf000004_0002
scheme-3
The reduction of N-alkylated compound of formula (7) where R is hydrogen or ethyl to a compound of formula (8) may be carried out using metal hydride reducing agents such as LAH or NaBH4/Iodine or NaBH /CH3SO3H or bis(2-methoxyethoxy)aluminum hydride (REDAL), in the presence of solvents such as diethylether, diisopropyl ether, tetrahydrofuran and the like. The temperature of the reaction may range from 5 °C - reflux temperature of the solvent used, preferably at a temperature in the range of 60 °C to reflux temperature. The yield of the resultant 2-[3,4-dihydro- l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) is in the order of 60-75 % and purity of 90-95 %. This compound can be used directly for the next step without purification. The reaction of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l- ethanol of the formula (8) with methane sulphonyl chloride may be carried out in the presence of an organic solvent such as DCE, DCM, toluene and the like, and an organic base such as triethylamine, tributylamine and the like. The final compound namely 2-[3,4-dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) is obtained in quantitative yield and of purity 99 %•
In another, embodiment of the present invention there is provided another process for the preparation of 2-[3,4-dihydro-l,4-benzothiazin-4- yl]ethylmethane sulphonate of the formula (1),
Figure imgf000005_0001
which comprises : i).. N-alkylating the 3,4-dihydro-l,4-benzothiazine of the formula (9) with 2- haloethanol of the formula (10) where X represents halogen atom . at a temperature in the range of 110-220 °C, in the presence of a base to get 2- [3 ,4- dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8), ii) mesylating the 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) obtained in step (i) to the compound of formula (1) by treating with methane sulphonyl chloride in the presence of an organic base and an organic solvent and (iii) isolating the compound of formula (1) by conventional methods.
The reaction is shown in scheme-4 below :
Figure imgf000006_0001
The N-alkylation of compound of formula (9) with 2-haloethanol of compound of the formula (10) wherein X represents halogen atom such as chlorine, bromine, fluorine or iodine in the step (i) may be carried out in the presence of base such as triethylamine, tributylamine, diisopropylamine, tetramethylguanidine and the like. The temperature for the reaction may range from 110 °C to 220 °C, preferably at 150-200 °C. The yield of the resultant 2- [3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) is in the order of 75-85 % and purity of ~ 90 %. This compound can be used directly for the next step without purification as the impurities can be eliminated in the subsequent steps. The reaction of 2-[3,4-dihydro-l54-benzothiazin-4-yl]-l- ethanol of formula (8) with methane sulphonyl chloride may be carried out in the presence of organic solvent such as DCM, DCE, toluene and the like and an organic base selected from ethylamine, tributylamine and the like. The final compound namely of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) is obtained in 70-80 % yield and of purity 99 %.
The invention is described in the examples given below which are provided by way of illustration only and therefore should not construed to limit the scope of the invention. Example 1
Step (i) : 2-r3,4-Dihvdro-l,4-benzothiazin-4-yl1-l-ethanol of the formula (8) : Lithium aluminum hydride (80 g) was added slowly under dry nitrogen atmosphere into 5 L 4 necked round bottom flask in about 30 min. The reaction mixture was cooled to 10-15 °C and THF (500 ml) was added dropwise in about 30-60 min. The reaction mixture was stirred at 10-15 °C for
10-15 min. and ethyl 2-(3-oxo-3,4-dihydro-l,4-benzothiazin-4-yl)acetate (100 g) in THF (500 ml) was added dropwise at 10-15 °C in about 2-3 h. The reaction mixture was maintained at reflux temperature for 3-4 h, by monitoring the reaction by TLC. The reaction mixture was cooled to 0-5 °C, and excess LAH was quenched with saturated sodium sulphate (1 L) solution slowly in about 2-3 h. The reaction mixture was diluted with toluene (2 L) and separated the organic layer by filtration. The organic layer was washed with water (2 x 500 ml), dried over Na2SO4 and evaporated the organic layer under reduced pressure and the traces of toluene were removed by applying high vacuum and the crude oil obtained was purified by high vacuum fractional distillation to afford 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8) as light brown oil (b.p (2-3 mm) 130-135° C, weighs about 60 g, yield 73 %, purity 92-95 %). Infrared absorption bands (cm"1): 3400 - 3300, 3060, 2925.
1H NMR (CDC13) : δ 3.00 (t, 2H), 3.40 (t, 2H), 3.60 (t, 2H), 3.80 (t, 2H), 6.60 - 6.80 (m, 2H), 6.90 - 7.10 (m, 2H). Mass spectrum (m/z) : 195 (M^), 164, 151.
Step (ii) : 2-r3,4-Dihydro-l,4-benzotl iazin-4-yllethylmethane sulphonate of the formula (1) :
To a solution of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8) (220 g) obtained in step (i) above in dichloromethane (1100 ml), triethyla ine (199 g, -275 ml) was added dropwise at 25 to 30 °C. M'ethanesulfonyl chloride (194 g, ~132 ml) was added to the above reaction mixture at 0-5 °C under stirring. The reaction mixture was maintained at 25 °C for 2-3 h, monitoring the reaction by TLC. Water (2 L) was added and the organic layer was separated. The aqueous layer was extracted with DCM (2 x 750 ml). The combined organic layers were washed with water (2 x 500 ml), dried over Na2SO4, filtered and evaporated under reduced pressure. The residue was triturated with petroleum ether (1000 ml) to afford crude 2-[3,4- dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) as dark grey solid (weighs about 250 g, yield 81 % purity 92-93 % by HPLC). To the crude compound of formula (1) methanol (500 ml) was added, stirred at 5- 10 °C for 1 h, filtered and dried to afford the pure 2-[3,4-dihydro-l,4- benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) as light grey solid, (weighs about 200 g, yield 65 %, mp 72-74 °C, purity 99 % by HPLC). Infrared absorption bands (cm"1): 3060, 2925, 1167. 1H NMR (CDC13) : δ 3.00 (s, 3H), 3.10 (t, 2H), 3.70 (dd, 4H), 4.40 (t, 2H), 6.60 - 7.20 (m, 4H). Mass spectrum (m/z) : 273 (M+), 195, 178, 164.
Example 2
Step (i) : 2-[3,4-Dihydro-l,4-benzothiazin-4-yn-l-ethanol of the formula (8) : Sodium borohydride (2.70 g) was taken in 250 ml 3 necked round bottom flask and THF (20 ml) was added with stirring under nitrogen atmosphere. Iodine (9.25 g) dissolved in THF (40 ml) was added to the above mixture of sodium borohydride at -10 to 0 °C in about 30-45 min. through addition funnel. Ethyl 2-(3-oxo-3,4-dihydro-l,4-benzothiazin-4-yl)acetate (7.6 g) dissolved in THF (25 ml) was added to the reaction mixture in about 10-20 min. at -10 to 0 °C. The reaction is highly exothermic initially and maintained gentle reflux of THF for 5-6 h, monitoring the reaction by TLC. The reaction mass was cooled to 0 to 10 °C and methanol (10 ml) was added slowly to quench the unreacted hydride and distill off the methanol under vacuum and the residue was diluted with DCM (150 ml). The DCM layer was washed with water (30 ml), dried over Na2SO4, distill off the DCM under reduced pressure in a rotavapour to obtain 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8) as an oil, (weighs about 4 g, yield 67 %, purity 92-95 % by HPLC).
Step (ii) : 2-r3,4-Dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) :
To a solution of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8) (8.3 g) obtained in step (i) above in dichloromethane (50 ml), triethylamine (6.5 g) was added dropwise under nitrogen atmosphere dropwise at 25 °C. Methanesulfonyl chloride (5.9 g, ~4.1 ml) was added to the above reaction mixture at 0 °C under stirring. The reaction mixture was maintained at 25 °C for 3 h, monitoring the reaction by TLC. Water (100 ml) was added and extracted with DCM (2 x 50 ml). The combined organic extracts were washed with water (50 ml), dried over Na2SO4, filtered and evaporated under reduced pressure. The residue was triturated with petroleum ether (40 ml) to afford crude 2-[3,4-dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) as grey solid, (weighs about 9.4 g, yield 81 % purity 92-93 % by HPLC). To the crude compound of formula (1), methanol (20 ml) was added, stirred at 5-10 °C for 1 h, filtered and dried to afford the pure 2-[3,4-dihydro- l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) as light grey solid, (weighs about 7.5 g, yield 67 %, purity 98.3 % by HPLC).
Example 3
Step (i) : 2-r3 -Dihvdro-l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) : Sodium borohydride (2.70 g) was taken in 250 ml 3 necked round bottom flask and THF (20 ml) was added under stirring under nitrogen atmosphere. Methane sulfonic acid (3.5 g) dissolved in THF (40 ml) was added to the above mixture of sodium borohydride at -10 to 0 °C in about 30-45 min. through addition funnel. Ethyl 2-(3-oxo-3,4-dihydro-l,4-benzothiazin-4- yl)acetate (7.6 g) dissolved in THF (25 ml) was added to the reaction mixture in about 10-20 min. at -10 to 0 °C. The reaction is highly exothermic initially and maintained gentle reflux of THF for 5-6 h, monitoring the reaction by TLC. The reaction mass was cooled to 0 to 10 °C and methanol (10 ml) was added slowly to quench the unreacted hydride and distill off the methanol under vacuum and the residue was diluted with DCM (150 ml). Washed the DCM layer with water (30 ml), dried over Na2SO4, and distill off the DCM under reduced pressure in a rotavapour to obtain 2-[3,4-dihydro-l,4- benzothiazin-4-yl]-l-ethanol of formula (8), (weighs about 4 g, yield 67 %, purity 92-98 %).
Step (ii) : 2-r3,4-Dihvdro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) :
To a solution of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8) (8.3 g) obtained in step (i) above in dichloromethane (50 ml), triethylamine (6.5 g) was added under nitrogen atmosphere dropwise at 25 °C. Methanesulfonyl chloride (5.9 g, ~4.1 ml) was added to the above reaction mixture at 0 °C under stirring. The reaction mixture was maintained at 25 °C for 3 h, monitoring the reaction by TLC. Water (100 ml) was added and extracted with DCM (2 x 50 ml). The combined organic layers were washed with water (50 ml), dried over Na2SO4, filtered and evaporated under reduced pressure. The residue was triturated with petroleum ether (40 ml) to afford crude 2-[3,4-dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) as grey solid, (weighs about 9.4 g, yield 81 % purity 92-93 % by HPLC). To the crude compound of formula (1) methanol (20 ml) was added, stirred at 5-10 °C for 1 h, filtered and dried to afford the pure 2-[3,4-dihydro- l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) as light grey solid, (weighs about 7.5 g, yield 67 %, purity 98 % by HPLC).
Example 4 Step (i) : 2-r3,4-Dihydro-l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) : To 3,4-dihydro-l,4-benzothiazine (200 g) taken in 2 L 4 necked round bottom flask, 2-chloroethanol (131 g, ~109 ml) and tributylamine (302 g, -393 ml) was added under stirring at 25 to 35 °C in one lot. The reaction mixture was heated to 170 to 180 °C under vigorous stirring and maintained the reaction mixture at that temperature for 4-6 h. Monitored the reaction by TLC. The reaction mixture was cooled to 25 to 35 °C and toluene (1 L) was added, washed the organic layer with water (3 x 1 L) and decolorized with activated charcoal. The decolorized organic layer was concentrated on rotavapor at 80- 90 °C under reduced pressure and the residual oil was stirred with petroleum ether (1 L) for 30 min. and separated the per. ether layer. Repeated the petroleum stirring for two times and separated the pet. ether insoluble oil to afford 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8), as dark brown thick oil, (b.p 2-3 mm 130-135 °C, weighs about 220-230 g, yield 84- 88 %, purity 89 % by HPLC).
Step (ii) : 2-r3,4-Dihvdro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) :
To a solution of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8) (220 g) obtained in step (i) above in dichloromethane (1100 ml), triethylamine (199 g, -275 mϊ) was added dropwise at 25 to 30 °C. Methanesulfonyl chloride (194g, -132 ml) was added to the above reaction mixture at 0 to 5 °C under stirring. The reaction mixture was maintained at 25 °C for 2-3 h, monitoring the reaction by TLC. Water (2 L) was added and extracted with DCM (2 x 750 ml). The combined organic layers were washed with water (2 x 500 ml), dried over Na2SO4, filtered and evaporated under reduced pressure. The residue was triturated with petroleum ether (1000 ml) to afford crude 2-[3,4-dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) as dark grey solid, (weighs about 250 g, yield 81 % purity 92- 93 % by HPLC). To the crude compound of formula (1) methanol (500 ml) was added, stirred at 5-10 °C for 1 h, filtered and dried to afford pure 2-[3,4- dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) as light grey solid, (weighs about 200 g, mp 72-74 °C, yield 65 %, purity 98 - 99 % by HPLC).
Example 5
Step (i) : 2-r3,4-Dihydro-l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) : To 3,4-dihydro-l,4-benzothiazine (200 g) taken in 2 L 4 necked round bottom flask, bromoethanol (206 g, -117 ml) and tributylamine (302 g, -393 ml) was added under stirring at 25 to 35 °C in one lot. The reaction mixture was heated to 170-180 °C under vigorous stirring and maintained the reaction mixture at that temperature for 4-6 h. Monitored the reaction by TLC. The reaction mixture was cooled to 25 to 35 °C and toluene (1 L) was added, washed the organic layer with water (3 x 1 L) and decolorized with activated charcoal. The decolorized organic layer was concentrated on rotavapor at 80 to 90 °C under reduced pressure and the residual oil was stirred with petroleum ether (1 L) for 30 min. and separated the pet. ether layer. Repeated the petroleum stirring for two times and separated the pet. ether insoluble oil to afford 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8), as dark brown thick oil, (b.p 2-3 mm 130-135 °C, weighs about 220-230 g, yield 84- 88 %, purity 89 % by HPLC).
Step (ii) : 2-r3,4-Dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) : To a solution of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8) (220 g) obtained in step (i) above in dichloromethane (1100 ml), triethylamine (199 g, -275 ml) was added under nitrogen atmosphere dropwise at 25 to 35 °C. Methanesulfonyl chloride (194 g, -132 ml) was added to the above reaction mixture at 0 to 5 °C under stirring. The reaction mixture was maintained at 25 °C for 2-3 h, monitoring the reaction by TLC. Water (2 L) was added and extracted with DCM (2 x 750 ml). The combined organic layers were washed with water (2 x 500 ml), dried over Na2SO , filtered and evaporated under reduced pressure. The residue was triturated with petroleum ether (1000 ml) to afford crude 2-[3,4-dihydro-l,4- benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) as dark grey solid, (weighs about 250 g, yield 81 % purity 92-93 % by HPLC). To the crude compound of formula (1) methanol (500 ml) was added, stirred at 5 to 10 °C for 1 h, filtered and dried to afford pure 2-[3,4-dihydro-l,4- benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) as light grey solid, (weighs about 200 g, mp 72-74 °C, yield 65 %, purity 98 - 99 % by HPLC).
Example 6 Step (i) : 2-r3,4-Dihydro-l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) : To 3,4-dil ydro-l,4-benzothiazine (200 g) taken in 2 L 4 necked round bottom flask, iodoethanol (284 g, -129 ml) and tributylamine (302 g, -393 ml) was added under stirring at 25 to 35 °C in one lot. The reaction mixture was heated to 170 to 180 °C under vigorous stirring and maintained the reaction mixture at that temperature for 4-6 h. Monitored the reaction by TLC. The reaction mixture was cooled to 25 to 35 °C and toluene (1 L) was added, washed the organic layer with water (3 x 1 L) and decolorized with activated charcoal. The decolorized organic layer was concentrated on rotavapor at 80 to 90 °C under reduced pressure and the residual oil was stirred with petroleum ether (1 L) for 30 min. and separated the pet. ether layer. Repeated the petroleum stirring for two times and separated the pet. ether insoluble oil to afford 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8), as dark brown thick oil, (b.p 2-3 mm 130-135 °C, weighs about 220-230 g, yield 84- 88 %, purity 89 % by HPLC).
Step (ii) : 2-r3,4-Dihydro-l,4-benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) :
To a solution of 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of formula (8) (220 g) obtained in step (i) above in dichloromethane (1100 ml), triethylamine (199 g, -275 ml) was added under nitrogen atmosphere dropwise at 25 to 35 °C. Methanesulfonyl chloride (194 g, -132 ml) was added to the above reaction mixture at 0 to 5 °C under stirring. The reaction mixture was maintained at 25 °C for 2-3 h, monitoring the reaction by TLC. Water (2 L) was added and extracted with DCM (2 x 750 ml). The combined organic layers were washed with water (2 x 500 ml), dried over Na2SO4, filtered and evaporated under reduced pressure. The residue was triturated with petroleum ether (1000 ml) to afford crude 2-[3,4-dihydro-l,4- benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) as dark grey solid, (weighs about 250 g, yield 81 % purity 92-93 % by HPLC). To the crude compound of formula (1) methanol (500 ml) was added, stirred at 5 to 10 °C for 1 h, filtered and dried to afford pure 2-[3,4-dihydro-l,4- benzothiazin-4-yl]ethylmethane sulphonate of the formula (1) as light grey solid, (weighs about 200 g, mp 72-74 °C, yield 65 %, purity 98 - 99 % by HPLC). Advantages of the Invention .
• The process does not require the use of expensive reagents and dry solvents, thereby making the process safe and economical. • The process is commercially viable and can be employed for the easy and quick preparation of the compounds of formula (1).

Claims

Claims :
1. A process for the preparation of 2-[3,4-dihydro-l,4-benzothiazin-4- yl]ethylmethane sulphonate of the formula (1)
Figure imgf000016_0001
which comprises : i). reducing the N-alkylated benzothiazine of the formula (7)
Figure imgf000016_0002
where R is hydrogen or ethyl in the presence of a solvent at a temperature in the range of 5 °C to reflux temperature, to get 2-[3,4-dihydro-l,4- benzothiazin-4-yl]-l-ethanol of formula (8)
Figure imgf000016_0003
ii): mesylating the 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l-ethanol of the formula (8) obtained in step (i) to the compound of formula (1) by treating with methane sulphonyl chloride in the presence of an organic base and an organic solvent and
(iii). isolating the compound of formula (1) by conventional methods.
2. The process as claimed in claim 1, wherein the reduction of N-alkylated compound of formula (7) may be carried out using metal hydride reducing agents such as LAH, NaBH4/Iodine, NaBH4/CH3SO3H or bis(2- methoxyethoxy)aluminum hydride (REDAL).
3. The process as claimed in claims 1 and 2, wherein the solvent used for reduction in step (i) is selected from diethylether, diisopropyl ether or tetrahydrofuran.
4. The process as claimed in claims 1 to 3, wherein the reduction in step (I) is carried out at a temperature of the reaction may range from 5 °C to reflux temperature of the solvent used, preferably at a temperature in the range of 60 °C to reflux temperature.
5. The process as claimed in claims 1 to 4, wherein the organic solvent used in step (ii) is selected from DCE, DCM or toluene.
6. The process as claimed in claims 1 to 5, wherein the organic base used in step (ii) is selected from triethylamine or tributylamine.
7. A process for the preparation of 2-[3,4-dihydro-l,4-benzothiazin-4- yljethylmethane sulphonate of the formula (1)
Figure imgf000017_0001
which comprises : i). N-alkylating the 3,4-dihydro-l,4-benzothiazine ofthe forιιιula (9)
Figure imgf000017_0002
with 2-haloethanol of the formula (10) χ^s/0H (10) where X represents halogen atom at a temperature in the range of 110-220 °C, in the presence of a base to get 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l- " ethanol of formula (8),
Figure imgf000018_0001
ii). mesylating the 2-[3,4-dihydro-l,4-benzothiazin-4-yl]-l -ethanol of the formula (8) obtained in step (i) to the compound of formula (1) by treating with methane sulphonyl chloride in the presence of an organic base and an organic solvent and (iii). isolating the compound of formula (1) by conventional methods.
8. The process as claimed in claim 7, wherein the base used for N- alkylation in step (i) is selected from triethylamine, tributylamine, diisopropylamine or tetramethylguanidine.
9. The process as claimed in claims 7 and 8, wherein the N-alkylation is carried out at a temperature in the range of 110 °C to 220 °C, preferably 150- 200 °C.
10. The process as claimed in claims 7-9, wherein the organic solvent used in step (ii) is selected from DCM, DCM or toluene.
11. The process as claimed in claims 7-10, wherein the organic base used in step (ii) is selected from triethylamine or tributylamine.
12. The process for the preparation of 2-[3.4-dihydro-l,4-benzothiazin-4- yl]ethylmethane sulphonate of the formula (1) substantially as herein described with reference to the examples.
PCT/IB2001/001614 2000-09-04 2001-09-03 Process for the preparation of 2-[3,4-dihydro-1,4-benzothiazin-4-yl]ethylmethane sulphonate WO2002020499A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001284335A AU2001284335A1 (en) 2000-09-04 2001-09-03 Process for the preparation of 2-(3,4-dihydro-1,4-benzothiazin-4-yl)ethylmethane sulphonate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN718MA2000 2000-09-04
IN718/MAS/2000 2000-09-04

Publications (1)

Publication Number Publication Date
WO2002020499A1 true WO2002020499A1 (en) 2002-03-14

Family

ID=11097184

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2001/001614 WO2002020499A1 (en) 2000-09-04 2001-09-03 Process for the preparation of 2-[3,4-dihydro-1,4-benzothiazin-4-yl]ethylmethane sulphonate

Country Status (2)

Country Link
AU (1) AU2001284335A1 (en)
WO (1) WO2002020499A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11209437B2 (en) 2016-07-20 2021-12-28 Fluorescence Diagnosis (Shanghai) Biotech Company Fluorescent probe and preparation method and use thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998052946A1 (en) * 1997-12-02 1998-11-26 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
WO1999020614A1 (en) * 1998-05-27 1999-04-29 Dr. Reddy's Research Foundation Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998052946A1 (en) * 1997-12-02 1998-11-26 Dr. Reddy's Research Foundation Azolidinediones useful for the treatment of diabetes, dyslipidemia and hypertension
WO1999020614A1 (en) * 1998-05-27 1999-04-29 Dr. Reddy's Research Foundation Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ARMENISE, D. ET AL: "Preparation of potentially bioactive aza and thiaza polycyclic compounds containing a bridgehead nitrogen atom. Synthesis ant antimicrobial activity of some pyrrolo[1,2,3-de]-1,4-benzothiazines", IL FARMACO, vol. 46, no. 9, 1991, pages 1023 - 1032, XP001055514 *
ELZ, S.; KELLER, A.: "Preparation and in vitro pharmacology of 5-HT4 receptor ligands. Partial Agonism and Antagonism of metoclopramide analogous benzoic esters", ARCH. PHARM., vol. 328, 1995, Weinheim, pages 585 - 594, XP001055529 *
PRASAD, RAJ N. ET AL: "chemistry and synthesis of some dihydro-2H-1,4-benzothiazine derivs.", CAN. J. CHEM., vol. 44, 1966, pages 1247 - 1258, XP001027730 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11209437B2 (en) 2016-07-20 2021-12-28 Fluorescence Diagnosis (Shanghai) Biotech Company Fluorescent probe and preparation method and use thereof

Also Published As

Publication number Publication date
AU2001284335A1 (en) 2002-03-22

Similar Documents

Publication Publication Date Title
Lee et al. Synthesis of the active diol epoxide metabolites of the potent carcinogenic hydrocarbon 7, 12-dimethylbenz [a] anthrene
EP0343474A2 (en) Process for the preparation of optically pure aminophenylthio- and aminoaphthalenylthio-propanoic acids
JPH08319290A (en) Imidazole derivative
WO2002020499A1 (en) Process for the preparation of 2-[3,4-dihydro-1,4-benzothiazin-4-yl]ethylmethane sulphonate
Attia et al. Synthesis, NMR conformational analysis and pharmacological evaluation of 7, 7a, 13, 14-tetrahydro-6 H-cyclobuta [b] pyrimido [1, 2-a: 3, 4-a′] diindole analogues as melatonin receptor ligands
US4423228A (en) Process for preparing N-(methyl-sulfonyl)-1,2,8,8a-cyclopropa[c]benzo[1,2-b:4,3-b']dipyrrol-4(5H)-one
Hardtmann et al. Synthesis and antiinflammatory activity of some 1-alkyl-4-phenylpyrido [2, 3-d] pyrimidin-2 (1H)-ones
JP2021176823A (en) Manufacturing method of dibenzo[g,p] chrysene derivative and novel dibenzo[g,p] chrysene derivative
KR100468288B1 (en) Method for producing 3,4-dihydroxy-3-cyclobutene-1,2-dione
EA000377B1 (en) PROCESS FOR THE SYNTHESIS OF BENZO[b]THIOPHENES
GB2119379A (en) Substituted sulphonanilides
CN108484481B (en) Synthesis method of dihydro-1H-indene spiro compound
KR900006857B1 (en) Highly soluble antibacterially active pyridobenzothiazines and its preparation
JP4157361B2 (en) Method for producing 9-spirofluorene compound
US5017574A (en) Novel imidazobenzodiazepines
FR2755691A1 (en) NOVEL SUBSTITUTED 7,12-DIOXA-BENZO [A] ANTHRACENIC DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
WO2002020498A2 (en) An improved process for the preparation of 3,4-dihydro-1,4-benzothiazine
Zhang et al. Total Synthesis of (±)‐Abieta‐8, 11, 13‐trien‐7β‐ol
Lácová Reaction of 2-benzothiazolylthioethanoic acid with phthalic anhydride under conditions of Gabriel modification of Perkin synthesis
Wang et al. Facile synthesis of 3-benzylsulfinyl-and 3-benzylsulfonyl-7-diethylaminocoumarins
Matsumura et al. Reaction of tetraazathiapentalene and thiadiazolopyrimidine derivatives with heterocumulenes: Cycloaddition and elimination reactions via hypervalent sulfur intermediates
CA2360456A1 (en) Novel process of preparing a benzothiazolone compound
WO2002034733A1 (en) An improved process for the preparation of 2-[phenoxazin-10-yl]ethylmethane sulphonate
Suzaka et al. Synthesis of sodium 3‐ethyl‐7‐isopropyl‐[2‐14C]‐azulene‐1‐sulfonate
WO2002040460A1 (en) A process for the preparation of 2-[phenothiazin-10-yl] ethyl methane sulphonate

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP